candesartan and histamine

candesartan has been researched along with histamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Abassi, RA; Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG1
Bleeke, T; Chen, X; Friedrich, S; Niroomand, F; Tiefenbacher, CP; Vahl, C1

Other Studies

3 other study(ies) available for candesartan and histamine

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Analysis of vasoconstrictor responses to histamine in the hindlimb vascular bed of the rabbit.
    The American journal of physiology, 1999, Volume: 277, Issue:4

    Topics: Adamantane; Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Vessels; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hindlimb; Histamine; Injections, Intravenous; Male; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Phentolamine; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Histamine; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents

1999
ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:4

    Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fluvastatin; Histamine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; Lisinopril; Male; Middle Aged; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Serotonin; Tetrazoles; Vascular Diseases; Vascular Resistance; Vasodilator Agents

2004